细菌感染的肠外初始治疗计算：多重耐药革兰氏阴性杆菌感染--ESBL 生产者、产碳青霉烯酶肠杆菌科细菌、耐碳青霉烯酶鲍曼不动杆菌。

GMS infectious diseases Pub Date : 2020-03-26 eCollection Date: 2020-01-01 DOI:10.3205/id000048

Béatrice Grabein, Michael Ebenhoch, Ernst Kühnen, Florian Thalhammer

{"title":"细菌感染的肠外初始治疗计算：多重耐药革兰氏阴性杆菌感染--ESBL 生产者、产碳青霉烯酶肠杆菌科细菌、耐碳青霉烯酶鲍曼不动杆菌。","authors":"Béatrice Grabein, Michael Ebenhoch, Ernst Kühnen, Florian Thalhammer","doi":"10.3205/id000048","DOIUrl":null,"url":null,"abstract":"This is the sixteenth chapter of the guideline \"Calculated initial parenteral treatment of bacterial infections in adults - update 2018\" in the 2nd updated version. The German guideline by the Paul-Ehrlich-Gesellschaft für Chemotherapie e.V. (PEG) has been translated to address an international audience. Infections due to multiresistant Gram-negative rods are challenging. In this chapter recommendations for targeted therapy for infections caused by ESBL-producing Enterobacteriaceae, carbapenemase-producing Enterobacteriaceae and carbapenem-resistant Acinetobacter baumannii are given, based on the limited available evidence.","PeriodicalId":91688,"journal":{"name":"GMS infectious diseases","volume":"8 ","pages":"Doc04"},"PeriodicalIF":0.0000,"publicationDate":"2020-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186793/pdf/","citationCount":"0","resultStr":"{\"title\":\"Calculated parenteral initial treatment of bacterial infections: Infections with multi-resistant Gram-negative rods - ESBL producers, carbapenemase-producing Enterobacteriaceae, carbapenem-resistant Acinetobacter baumannii.\",\"authors\":\"Béatrice Grabein, Michael Ebenhoch, Ernst Kühnen, Florian Thalhammer\",\"doi\":\"10.3205/id000048\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"This is the sixteenth chapter of the guideline \\\"Calculated initial parenteral treatment of bacterial infections in adults - update 2018\\\" in the 2nd updated version. The German guideline by the Paul-Ehrlich-Gesellschaft für Chemotherapie e.V. (PEG) has been translated to address an international audience. Infections due to multiresistant Gram-negative rods are challenging. In this chapter recommendations for targeted therapy for infections caused by ESBL-producing Enterobacteriaceae, carbapenemase-producing Enterobacteriaceae and carbapenem-resistant Acinetobacter baumannii are given, based on the limited available evidence.\",\"PeriodicalId\":91688,\"journal\":{\"name\":\"GMS infectious diseases\",\"volume\":\"8 \",\"pages\":\"Doc04\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-03-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186793/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"GMS infectious diseases\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3205/id000048\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2020/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"GMS infectious diseases","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3205/id000048","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

这是《成人细菌感染的初始肠外治疗计算指南--2018 年更新版》第 2 次更新版中的第十六章。由保罗-埃利希化疗协会（Paul-Ehrlich-Gesellschaft für Chemotherapie e.V.，PEG）制定的德国指南已被翻译成国际版本。多重耐药革兰氏阴性杆菌引起的感染具有挑战性。本章将根据有限的现有证据，为产 ESBL 肠杆菌科细菌、产碳青霉烯酶肠杆菌科细菌和耐碳青霉烯类鲍曼不动杆菌引起的感染提供靶向治疗建议。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

摘要图片

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

Calculated parenteral initial treatment of bacterial infections: Infections with multi-resistant Gram-negative rods - ESBL producers, carbapenemase-producing Enterobacteriaceae, carbapenem-resistant Acinetobacter baumannii.

This is the sixteenth chapter of the guideline "Calculated initial parenteral treatment of bacterial infections in adults - update 2018" in the 2^nd updated version. The German guideline by the Paul-Ehrlich-Gesellschaft für Chemotherapie e.V. (PEG) has been translated to address an international audience. Infections due to multiresistant Gram-negative rods are challenging. In this chapter recommendations for targeted therapy for infections caused by ESBL-producing Enterobacteriaceae, carbapenemase-producing Enterobacteriaceae and carbapenem-resistant Acinetobacter baumannii are given, based on the limited available evidence.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

GMS infectious diseases

自引率

0.00%

发文量

审稿时长

17 weeks